(Q51343741)
Statements
Efficacy, safety and dose-response relationship of teneligliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus. (English)
1 reference
T Kadowaki
1 reference
K Kondo
1 reference
7 April 2013
1 reference
15
1 reference
9
1 reference
810-818
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference